Related references
Note: Only part of the references are listed.Near Infrared Photoimmunotherapy in the Treatment of Pleural Disseminated NSCLC: Preclinical Experience
Kazuhide Sato et al.
THERANOSTICS (2015)
Near Infrared Photoimmunotherapy in the Treatment of Disseminated Peritoneal Ovarian Cancer
Kazuhide Sato et al.
MOLECULAR CANCER THERAPEUTICS (2015)
A phase 1/2 of a combination of Cetuximab and Taxane for triple negative breast cancer patients
Hovav Nechushtan et al.
BREAST (2014)
The Effect of Photoimmunotherapy Followed by Liposomal Daunorubicin in a Mixed Tumor Model: A Demonstration of the Super-Enhanced Permeability and Retention Effect after Photoimmunotherapy
Kohei Sano et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Photoimmunotherapy: Comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor
Kazuhide Sato et al.
MOLECULAR ONCOLOGY (2014)
Photoimmunotherapy of Gastric Cancer Peritoneal Carcinomatosis in a Mouse Model
Kazuhide Sato et al.
PLOS ONE (2014)
Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
Hisataka Kobayashi et al.
THERANOSTICS (2014)
Markedly Enhanced Permeability and Retention Effects Induced by Photo-immunotherapy of Tumors
Kohei Sano et al.
ACS NANO (2013)
Triple-Negative Breast Cancer and the Need for New Therapeutic Targets
Olav Engebraaten et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Imaging the efficacy of UVC irradiation on superficial brain tumors and metastasis in live mice at the subcellular level
Masashi Momiyama et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Randomized Phase II Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer
Jose Baselga et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Improving the Efficacy of Photoimmunotherapy (PIT) using a Cocktail of Antibody Conjugates in a Multiple Antigen Tumor Model
Takahito Nakajima et al.
THERANOSTICS (2013)
Targeting triple-negative breast cancer: optimising therapeutic outcomes
K. Gelmon et al.
ANNALS OF ONCOLOGY (2012)
Near-infrared Theranostic Photoimmunotherapy (PIT): Repeated Exposure of Light Enhances the Effect of Immunoconjugate
Makoto Mitsunaga et al.
BIOCONJUGATE CHEMISTRY (2012)
Basal Breast Cancer: A Complex and Deadly Molecular Subtype
F. Bertucci et al.
CURRENT MOLECULAR MEDICINE (2012)
The ERBB network: at last, cancer therapy meets systems biology
Yosef Yarden et al.
NATURE REVIEWS CANCER (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice
M. Gil et al.
BRITISH JOURNAL OF CANCER (2011)
Use of Standard Markers and Incorporation of Molecular Markers Into Breast Cancer Therapy Consensus Recommendations From an International Expert Panel
Manfred Kaufmann et al.
CANCER (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
Makoto Mitsunaga et al.
NATURE MEDICINE (2011)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor 2 (HER2), and Epidermal Growth Factor Receptor Expression and Benefit From Lapatinib in a Randomized Trial of Paclitaxel With Lapatinib or Placebo As First-Line Treatment in HER2-Negative or Unknown Metastatic Breast Cancer
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies
Tristan Barrett et al.
CLINICAL CANCER RESEARCH (2007)
A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancer
Shanu Modi et al.
CLINICAL BREAST CANCER (2006)
Tumor vascular permeabilization by vascular-targeting photosensitization: Effects, mechanism, and therapeutic implications
B Chen et al.
CLINICAL CANCER RESEARCH (2006)
Monoclonal antibody successes in the clinic
JM Reichert et al.
NATURE BIOTECHNOLOGY (2005)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
